Yahoo Web Search

Search results

1. CytomX Therapeutics, Inc.

   NasdaqGS: CTMX

   1.3000

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.0100 (+0.78%)

   At close: Mon. Jul 8, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1.3000
     High	1.3900
     Low	1.2900

   • Mkt Cap	101.3M
     P/E (TTM)	6.19
     Div & Yield	N/A & N/A

   • Prev. Close	1.2900
     52 Wk. Low	1.0400
     52 Wk. High	5.8500

   More about CTMX

   Related stocks

   • ASMB
     Assembly Biosciences, Inc.
     ASMB
     13.85
     +4.84%
   • KALA
     KALA BIO, Inc.
     KALA
     6.81
     -1.30%
   • MGNX
     MacroGenics, Inc.
     MGNX
     4.2300
     +0.71%
   • MRSN
     Mersana Therapeutics, Inc.
     MRSN
     1.8800
     +2.73%
   • ATRA
     Atara Biotherapeutics, Inc.
     ATRA
     7.96
     -3.86%

   More on Yahoo Finance

2. www.marketbeat.com › stocks › NASDAQCytomX Therapeutics (CTMX) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · Should You Buy or Sell CytomX Therapeutics Stock? Get The Latest CTMX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

   • 4.6/5
   • Email: ckeenan@cytomx.com

   • Phone: (605) 515-3185
   • Employees: 120

3. www.bloomberg.com › quote › CTMX:USCTMX: CytomX Therapeutics Inc Stock Price Quote - NASDAQ GS ...

   www.bloomberg.com › quote › CTMX:US

   • Cached

   3 days ago · Stock analysis for CytomX Therapeutics Inc (CTMX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 120

4. stockanalysis.com › stocks › ctmxCytomX Therapeutics, Inc. (CTMX) - Stock Analysis

   stockanalysis.com › stocks › ctmx

   • Cached

   3 days ago · CytomX Therapeutics is a biotech company developing conditionally activated biologic therapeutics for cancer. See its stock price, news, financials, statistics, forecast, profile and chart on Stock Analysis.

   • Market Cap: 94.28M
   • Revenue (ttm): 119.18M

   • Net Income (ttm): 16.53M
   • Shares Out: 77.92M

5. stockanalysis.com › stocks › ctmxCytomX Therapeutics, Inc. (CTMX) Stock Forecast & Price ...

   stockanalysis.com › stocks › ctmx

   • Cached

   5 days ago · The 4 analysts with 12-month price forecasts for CytomX Therapeutics stock have an average target of 5.77, with a low estimate of 3.50 and a high estimate of 8.00. The average target predicts an increase of 343.85% from the current stock price of 1.30.

6. www.marketscreener.com › quote › stockCytomX Therapeutics, Inc. Stock (CTMX) - Quote Nasdaq ...

   www.marketscreener.com › quote › stock

   • Cached

   3 days ago · Latest news about CytomX Therapeutics, Inc. Piper Sandler Upgrades CytomX Therapeutics to Overweight From Neutral, Adjusts Price Target to $3.50 From $2.25. May. 28. MT. BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating. May. 09.

   • 0.3/5 (5)

   • Brand: CYTOMX THERAPEUTICS, INC.

7. stockanalysis.com › stocks › ctmxCytomX Therapeutics, Inc. (CTMX) Statistics ... - Stock Analysis

   stockanalysis.com › stocks › ctmx

   • Cached

   5 days ago · Detailed statistics for CytomX Therapeutics, Inc. (CTMX) stock, including valuation metrics, financial numbers, share information and more.

8. People also ask

   What does CytomX Therapeutics Inc (ctmx) do?

   • The Company focuses on developing probody therapeutics for the treatment of cancer. CytomX Therapeutics serves pharmaceutical industries throughout the United States. Stock analysis for CytomX Therapeutics Inc (CTMX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   CTMX: CytomX Therapeutics Inc Stock Price Quote - NASDAQ GS - Bloo…

   www.bloomberg.com/quote/CTMX:US

   See all results for this question

   Should you buy ctmx (ctmx) stock?

   • The average target predicts an increase of 347.29% from the current stock price of 1.29. The average analyst rating for CTMX stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

   CytomX Therapeutics, Inc. (CTMX) Stock Forecast & Price Targets - Stoc…

   stockanalysis.com/stocks/ctmx/forecast/

   See all results for this question

   What are analysts' price targets for ctmx (ctmx)?

   • Their CTMX share price targets range from $3.50 to $8.00. On average, they expect the company's share price to reach $5.77 in the next twelve months. This suggests a possible upside of 351.0% from the stock's current price. View analysts price targets for CTMX or view top-rated stocks among Wall Street analysts.

   CytomX Therapeutics (CTMX) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/CTMX/

   See all results for this question

   How did CytomX Therapeutics (ctmx) perform in the quarter?

   • CytomX Therapeutics, Inc. (NASDAQ:CTMX) released its quarterly earnings results on Wednesday, May, 8th. The biotechnology company reported $0.17 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.23. The biotechnology company earned $41.46 million during the quarter, compared to analysts' expectations of $23.40 million.

   CytomX Therapeutics (CTMX) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/CTMX/

   See all results for this question

9. www.morningstar.com › stocks › xnasCTMX - CytomX Therapeutics Inc Trailing Returns | Morningstar

   www.morningstar.com › stocks › xnas

   • Cached

   4 days ago · Stay up to date on how CytomX Therapeutics Inc (CTMX:XNAS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.